Quarterly report pursuant to Section 13 or 15(d)

Note 12 - Stock-based Compensation and Other Benefit Plans - Weighted Average Assumptions (Details)

v3.23.3
Note 12 - Stock-based Compensation and Other Benefit Plans - Weighted Average Assumptions (Details) - $ / shares
9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Weighted average exercise price - ($/share) (in dollars per share) $ 4.19 $ 6.41
Expected life in years (Year) 6 years 4 months 24 days 6 years
Average expected volatility 68.00% 72.00%
Risk-free interest rate 3.73% 1.98%
Expected dividend yield 5.97% 2.30%
Weighted average grant date fair value - ($/share) (in dollars per share) $ 2.29 $ 2.84